1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014

Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014" provides data on the Gaucher’s Disease Type I clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher’s Disease Type I. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gaucher’s Disease Type I. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Gaucher's Disease Type I Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Gaucher's Disease Type I 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Gaucher's Disease Type I 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Gaucher's Disease Type I Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Gaucher's Disease Type I 29
Oct 02, 2012: Genzyme Announces Phase III Study Of Oral Compound Eliglustat Tartrate For Gaucher Disease Meets Primary Endpoint 29
Feb 08, 2012: Genzyme Announces Four-Year Follow-Up Data From Patients Enrolled In Phase II Clinical Trial Of Eliglustat Tartrate 29
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Shire Plc 31
Clinical Trial Overview of Shire Plc 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
Amicus Therapeutics, Inc. 33
Clinical Trial Overview of Amicus Therapeutics, Inc. 33
Actelion Ltd 34
Clinical Trial Overview of Actelion Ltd 34
ExSAR Corporation 35
Clinical Trial Overview of ExSAR Corporation 35
Clinical Trial Overview of Top Institutes / Government 36
Istituto Giannina Gaslini 36
Clinical Trial Overview of Istituto Giannina Gaslini 36
Academic Medical Center 37
Clinical Trial Overview of Academic Medical Center 37
Five Key Clinical Profiles 38
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 88

List of Tables
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Region, 2014* 6
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Gaucher's Disease Type I Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Gaucher's Disease Type I Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Gaucher's Disease Type I Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Gaucher's Disease Type I Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 12
Gaucher's Disease Type I Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Gaucher's Disease Type I Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Gaucher's Disease Type I Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 31
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 32
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Amicus Therapeutics, Inc., 2014* 33
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 34
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by ExSAR Corporation, 2014* 35
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2014* 36
Gaucher's Disease Type I Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 37

List of Figures
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Gaucher's Disease Type I Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Gaucher's Disease Type I Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Gaucher's Disease Type I Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Gaucher's Disease Type I Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 12
Gaucher's Disease Type I Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Gaucher's Disease Type I Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Gaucher's Disease Type I to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Gaucher's Disease Type I Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Gaucher's Disease Type I Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Gaucher's Disease Type I Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Gaucher's Disease Type I Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
GlobalData Methodology 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.